7 results found.

Extraocular Retinoblastoma Clinical Trial using autologous bone marrow transplantation; autologous hematopoietic stem cell transplantation; in vitro-treated peripheral blood stem cell transplantation; cisplatin; cyclophosphamide; etoposide; filgrastim; carboplatin; vincristine sulfate; thiotepa; radiation therapy

Children's Oncology Group - Recruiting N/A to 10 years.
- A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma.
autologous bone marrow transplantation; autologous hematopoietic stem cell transplantation; in vitro-treated peripheral blood stem cell transplantation; cisplatin; cyclophosphamide; etoposide; filgrastim; carboplatin; vincristine sulfate; thiotepa; radiation therapy

Retinoblastoma Clinical Trial using Melphalan hydrochloride

Sidney Kimmel Comprehensive Cancer Center - Recruiting N/A to 18 years.
- Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma.
Melphalan hydrochloride

Sarcoma, Endocrine Tumors, Neuroblastoma, Retinoblastoma, or Rena Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies.

Retinoblastoma Clinical Trial using Temozolomide

Stanford University - Recruiting N/A to 21 years.
- Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala.
Temozolomide

Retinoblastoma Clinical Trial using filgrastim; carboplatin; cyclosporine; etoposide; vincristine sulfate; cryosurgery; laser therapy; neoadjuvant therapy

The Hospital for Sick Children - Recruiting N/A or older.
- Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003).
filgrastim; carboplatin; cyclosporine; etoposide; vincristine sulfate; cryosurgery; laser therapy; neoadjuvant therapy

Retinoblastoma Clinical Trial

Hadassah Medical Organization - Recruiting 1 year to 18 years.
- Quality of Life in Children Cured of Retinoblastoma.

Retinoblastoma Clinical Trial using subtenon Carboplatin; Topotecan Hydrochloride; Vincristine; Filgrastim

Children's Hospital Medical Center, Cincinnati - Recruiting N/A to 10 years.
- A Pilot Study of Intravenous Topotecan and Vincristine in Combination With Subconjunctival Carboplatin for Patients With a History of Bilateral Retinoblastoma and Refractory/Recurrent Intraocular Disease (IND# 104,942).
subtenon Carboplatin; Topotecan Hydrochloride; Vincristine; Filgrastim